Showing results (1111-1120 of 1,427) with videos related to
Sort By:
Pageof 143
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase InhibitionStephanie Lheureux, Jeff P Bruce, Julia V Burnier, et al.Scientific Reports|March 4, 2022
Clinical validation of a multiplex PCR-based detection assay using saliva or nasopharyngeal samples for SARS-Cov-2, influenza A and BNikhil S Sahajpal, Ashis K Mondal, Sudha Ananth, et al.American Journal of Obstetrics and Gynecology|June 26, 2021
Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferencesAinhoa Madariaga, Gita Bhat, Michelle K Wilson, et al.Gynecologic Oncology|April 23, 2016
A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancerJosep María Del Campo, Michael Birrer, Craig Davis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trialMace L Rothenberg, Amit M Oza, Robert H Bigelow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortiaAgustin A Garcia, Hal Hirte, Gini Fleming, et al.Human Mutation|January 25, 2021
Molecular characterization of pathogenic OTOA gene conversions in hearing loss patientsSacha Laurent, Corinne Gehrig, Thierry Nouspikel, et al.Scientific Reports|August 8, 2022
Alterations to the broad-spectrum formin inhibitor SMIFH2 modulate potency but not specificityMarina Orman, Maya Landis, Aisha Oza, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 5, 2022
Interobserver and intraobserver variability of RECIST assessment in ovarian cancerMichael Krasovitsky, Yeh Chen Lee, Hao-Wen Sim, et al.Journal of Immigrant and Minority Health|April 7, 2012
Migration status in relation to clinical characteristics and barriers to care among youth with diabetes in the USLindsay M Jaacks, Reena Oza-Frank, Ralph D'Agostino, et al.Pageof 143